Caso Clínico: Tratamiento del cáncer de vejiga localmente avanzado - page 13

HR .99 IC 95: .91-1.08

HR 1.08 IC 95: 1.00-1.16

Sexo

Edad

Comorbilidad

SG 5 años/CR

SG 5 años /RT

Varón

sin

55% (IC95: 51-65)

53% (IC95: 48-51)

Mujer

moderada

31% (IC95: 27-35)

28% (IC95: 24-33)

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,3,4,5,6,7,8,9,10,11,12 14,15,16,17,18,19,20,21,22,23,...27